Monitra Health gains US patent for advanced wireless cardiac monitoring technology

Monitra Healthcare a provider of health monitoring technologies announces the grant of its US Patent No. 12,109,029 B2, titled Wireless Cardiac Monitoring Device and Method to Measure and Transmit Cardiac Physiological Signals. This patent was issued by the United States Patent and Trademark Office on October 8, 2024.

The patented technology introduces a wireless patch-based cardiac monitoring device designed for patient compliance and diagnostic accuracy. The patch can automatically detect its orientation on the patient and optimally selects electrode pairs to ensure the highest quality signal transmission, eliminating errors from improper placement. The device processes bio-potential signals in real time and wirelessly transmits physiological data to external systems for further analysis.

The innovation features advanced orientation detection to reliably identify and adapt to the patch’s placement on the patient. Its electrode pairing optimises performance by automatically selecting the most effective electrode pairs based on real-time orientation and signal quality. Wireless connectivity enables efficient transmission of ECG and other physiological data to external devices for immediate processing and analysis.

Monitra Health’s patented technology aims to aid ambulatory ECG monitoring, particularly for conditions like atrial fibrillation and other cardiac arrhythmias and QT prolongation monitoring in cardiac safety studies in clinical trials. The company plans to commercialise this technology, expanding its presence in key markets, including the US, UK, and Australia.